the role of bicuspid aortic valve hemodynamics in the ...

2 downloads 0 Views 2MB Size Report
Hemodynamic Theory. • Altered valvular geometry leads to alterations in the hemodynamic environment, causing more mechanical abnormalities on the aortic ...
THE ROLE OF BICUSPID AORTIC VALVE HEMODYNAMICS IN THE DEVELOPMENT OF ACUTE AORTIC DILATION Samantha Ratley, Philippe Sucosky University of Notre Dame Department of Aerospace & Mechanical Engineering

THE BICUSPID AORTIC VALVE leftcoronary leaflet

rightcoronary leaflet

noncoronary leaflet

Tricuspid aortic valve (TAV)

raphe

fused leaflet

noncoronary leaflet

Type-I bicuspid aortic valve (BAV)

• BAV is the most common form of cardiac anomalies, affecting 2-3% of the population (Hoffman 2002; Basso 2004; Cozijnsen 2011) • BAV imparts the highest amount of disease compared to all other genetic heart diseases combined (Ward 2000; Siu & Silversides 2010)

BAV IS LINKED TO AORTIC DISEASE BAV Risks Associated Risk

Chance

BAV Inheritance (1st Degree Relative)

10-17%

Aortic Valve Stenosis

40-53% (80-95%*)

(2)

Aortic Valve Replacement

50-80%

(3)

Aortic Dilation

35-68%

(4)

Aortic Dissection

7-13%

(5)

Aortic Aneurysm

26-50%

(6)

Aortic Coarctation

20% (22-42%*)

(7)

(1) Cripe et al. 2004 (2) Lewin & Otto 2005; Losenno et al. 2012 (3) Etz et al. 2001 (4) Braverman et al. 1996; Tzemos et al. 2008; Nistri et al. 2008; Beroukhim et al. 2006 (5) Yuan et al. 2010 (6) Mayo Clinic; Lewin & Otto 2005 (7) Warnes 2003

(1)

ASCENDING AORTIC DILATION • Diameter > 4.0 cm (Cozijnsen 2011; Lu 2013) • Thinning of ascending aorta (AA) wall – Smooth muscle cell apoptosis (Della Corte 2007)

– Elastic fiber degeneration (Antanas 2011)

– Decreased Fibrillin-1 (Tandros 2009) – Increased MMP-2 and MMP-9 (Longo 2002)

• Asymptomatic

(Tzemos 2008)

– Only 10% of aneurysms (>4.5 cm are noticed)

• Dilation can lead to dissection CT Scan of Dilated Ascending Aorta (Al Attar 2008)

– ≥ 5.0 cm (Lu 2013) – 50% mortality rate in the first 48 hours (Antanas 2011)

BAV AORTOPATHY: CONTROVERSIAL ETIOLOGIES Genetic Theory • Intrinsic weakening of the aortic wall is caused by the same congenital defect that causes BAV

Hemodynamic Theory •



Altered valvular geometry leads to alterations in the hemodynamic environment, causing more mechanical abnormalities on the aortic wall in BAV than TAV Asymmetric presentation of dilation at the aortic convexity spatial distribution in shear stress •

• Currently, there is no established genetic link between BAV inheritance and aortic wall weakness

4D MRI (Hope et al. 2010), FEA (Viscardi et al. 2010), FSI (Cao et al. 2013), PIV (Saikrishnan et al. 2012)

• The causality between abnormal wall stress and aortic medial degeneration has not yet been demonstrated

FLUID-STRUCTURE INTERACTION (FSI) COMPLIMENTS IN VIVO DATA FSI (Cao et al. 2013, submitted ATVB)

right

left

volume flow rate (L/min)

-5

left

right

TAV BAV

20

0

right

left

anterior posterior

right

anterior posterior

anteriorposterior

left

anterior posterior

right

time (s) 0.86

left

Velocity magnitude (m/s) 0

0.6

TAV anterior posterior

BAV

anteriorposterior

TAV

4D MRI (Hope et al. 2010)

1.2

right

left

BAV

HEMODYNAMIC THEORY OF BAV AORTOPATHY BAV anatomic abnormality

hemodynamic stress abnormalities structural/ hemodynamic changes

HEMODYNAMIC

signal transduction

THEORY OF

AORTIC DILATION

AORTIC DILATION

biological changes (inflammation, proteases and remodeling)

MOTIVATION

acceleration phase

deceleration phase

3

TAV AA BAV AA

2.5 2 1.5 1 0

peak systole

0.43 time (s)

0.86

surface-averaged longitudinal WSS (dyn/cm2)

surface-averaged circumferential stretch (%)

• FSI studies closely mimic clinical data • BAV anatomy mostly impacts fluid wall shear stress (WSS) in the ascending aorta acceleration phase

deceleration phase

40

TAV AA BAV AA

20 0 -20 0

peak systole

0.43 time (s)

• Previous studies focus on already dilated aortic tissue in patients that have BAV

0.86

HYPOTHESIS AND OBJECTIVES • Hypothesis: Abnormal wall shear stress (WSS) experienced by a BAV ascending aorta contributes to the development of acute aortic dilation

• Objective: To study the effect of BAV WSS on aortic remodeling in the absence of any underlying aortic wall congenital defect

EX VIVO METHODOLOGY WSS WAVEFORMS

Longitudinal WSS (dyn/cm2)

• Temporal variations of the longitudinal WSS predicted at the center of the TAV ascending aorta (AA) and BAV AA convexity over one cardiac cycle.

40

acceleration phase deceleration phase

TAV AA BAV AA

20

0

-20

0

peak systole

central region of wall convexity

0.43

0.86

time (s)

(Cao et al. 2013, Submitted ATVB)

EX VIVO METHODOLOGY TISSUE ISOLATION AND CONDITIONING • •

Biopsy punches were sutured to theexposed tissue Normal A longitudinal The endothelium ascending cut of was aortas the made aorta dissected along was the from top of mounting plate porcine the aorta hearts attained7for a local Tissue biopsy punches mm in diameter were slaughterhouse taken from the disease-prone convexity with a custom biopsy punch intact aorta

mounting plate

endothelial surface exposed to flow

tissue samples location tissue samples sutured on plate

(Cao et al. 2013, Submitted ATVB)

EX VIVO METHODOLOGY TISSUE CONDITIONING • Tissue mounting plate was inserted into cone and plate bioreactor to replicate WSS environments of TAV and BAV AAs servo motor reservoir

servo drive

pump rotating cone pump

laptop computer culture medium tissue samples

perfusion system

mounting plate

pump

pump

(Sucosky 2008, Sun 2011)

EX VIVO METHODOLOGY TISSUE CONDITIONING TAV AA WSS Waveform

BAV AA WSS Waveform

(Sucosky 2008, Sun 2011)

CULTURE CONDITIONS, BIOMARKERS, AND ASSAYS Sample Group Control TAV AA WSS BAV AA WSS

Culture Duration

Culture Condition

0 hr

Fresh tissue

48 hr

10% FBS in DMEM with 1% antibiotics

Biomarker

Function

MMP-2

Degrades collagen and elastin

MMP-9

Degrades collagen and laminin

Fibrillin-1

Binds smooth muscle cells to elastin

Assay (Sample Size) IHC (N=3), WB (N=4), Z (N=4) IHC (N=3)

Immunohistochemistry (IHC), Western Blot (WB), Zymography (Z)

BAV HEMODYNAMICS PROMOTES MMP-2 AND MMP-9 EXPRESSION IN ASCENDING AORTIC TISSUE TAV AA WSS

BAV AA WSS

MMP-9

MMP-2

Control

Fibrillin-1

200 μm

(Cao et al. 2013, Submitted ATVB)

BAV HEMODYNAMICS PROMOTES MMP-2 AND MMP-9 EXPRESSION IN ASCENDING AORTIC TISSUE Control TAV AA WSS

BAV AA WSS

pro MMP-2 active MMP-2 MMP-9 β-actin

* Indicates significance versus Fresh (control) p